Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.

Site Map

Site Map of http://www.researchandmarkets.com


- Site Map
- Pharmaceuticals and Healthcare
   - Pharmaceuticals 1 (Latest Titles)
   Pharmaceuticals 2  << You are in This Category
   Pharmaceuticals 3
   Pharmaceuticals 4

   - Companies
   - Drug Delivery
   - Markets
   - OTC
   - Respiratory
   - Vitamins
   - Drug Discovery
   - Technology
   - E-Healthcare
   - Cardiovascular
   - Central Nervous System
   - Generics
   - Genomics
   - Immune Disorders
   - Infectious Diseases
   - Oncology
   - Pharmacoeconomics
   - Women's Health
   - Fast Facts
   - Analgesics




#  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  


^ Top



E

eHealth Solution Trend Tool: Disease Management static version printer friendly pdf version
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, Patient Compliance and Clinical Trials static version printer friendly pdf version
Eisai - Pipeline - Products - Performance - Potential static version printer friendly pdf version
Eisai Co Ltd Deals Briefing static version printer friendly pdf version
Electronic Data Capture and Management: Assessing Opportunities to Streamline the Clinical Trial Process static version printer friendly pdf version
Electronic Prescribing: Maintaining Leverage in the Future Prescribing Process static version printer friendly pdf version
Electronic Sampling: Influencing Physician Prescribing Behavior Through More Efficient Sampling Approaches static version printer friendly pdf version
Emerging Antiviral Drug Targets static version printer friendly pdf version
Emerging Cancer Therapeutics static version printer friendly pdf version
Emerging Markets for Stone Management Devices static version printer friendly pdf version
Emerging Markets in Hip Replacement static version printer friendly pdf version
Emerging Markets in Infertility: Treatment Trends in Select Asian, Central and Eastern European, and Latin American Markets static version printer friendly pdf version
Emerging Markets in Trauma Devices static version printer friendly pdf version
Emerging Markets Series: Benchmarking Key Countries Brazil, Russia, India, China and Turkey static version printer friendly pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version
Emerging Pharmaceutical Markets Globally static version printer friendly pdf version
Emerging Pharmaceutical Markets: Growth Opportunities, Changing Healthcare Dynamics and Regulatory Trends static version printer friendly pdf version
Emerging Technologies in Hip Implants: Low-Wear Solutions for Total Hip Replacement static version printer friendly pdf version
Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies static version printer friendly pdf version
Emerging Therapies to Treat Lupus Erythematosus static version printer friendly pdf version
Emerging U.S. EDetailing Markets for Life Sciences static version printer friendly pdf version
Enablex U.S. Sales, 2005-2011 static version printer friendly pdf version
Endometriosis - Growing the Patient Population is Key to Unlocking the Markets Commercial Potential static version printer friendly pdf version
Ephedrine Production & Market in China  static version printer friendly pdf version
Epidemiology-Based Market Forecasting: Pros and Cons static version printer friendly pdf version
Erectile Dysfunction Drugs in Japan: Marketing Issues and Strategies static version printer friendly pdf version
Erythropoietin Current Market Dynamics & Future Outlook static version printer friendly pdf version
Erythropoietin State-of-the-Science and Strategic Opportunities static version printer friendly pdf version
Erythropoietin, Current Market Dynamics & Future Outlook static version printer friendly pdf version
Essential Statistics for the Pharmaceutical Sciences static version printer friendly pdf version
Estonia Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Estonia Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Estonia Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
EU Paediatric Medicines Regulation: Boon or Burden? static version printer friendly pdf version
Europe CoenzymeQ10 Markets static version printer friendly pdf version
European Antidepressant Drug Markets static version printer friendly pdf version
European Antidepressants Markets static version printer friendly pdf version
European Antiviral Drug and Vaccine Markets static version printer friendly pdf version
European Cardiology PACS Markets static version printer friendly pdf version
European Central Nervous System (CNS) Therapeutics Markets static version printer friendly pdf version
European Clinical Trial Applications static version printer friendly pdf version
European Countries Market Value Of Adhesive Dressings Or Similar Articles; Impregnated Or Coated With Pharmaceutical Substances; Or Put Up In Forms For Retail Sale static version printer friendly pdf version
European Countries Market Value Of Antisera And Other Blood Fractions static version printer friendly pdf version
European Countries Market Value Of Blood-Grouping Reagents static version printer friendly pdf version
European Countries Market Value Of Chemical Contraceptive Preparations Based On Hormones Or Spermicides static version printer friendly pdf version
European Countries Market Value Of First-Aid Boxes And Kits static version printer friendly pdf version
European Countries Market Value Of Gel Preparations For Use In Human Or Veterinary Medicine As A Lubricant For Surgical Operations Or Physical Examinations Or As A Coupling Agent Between The Body And Medical Instruments static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Corticosteroid Hormones, Their Derivatives And Structural Analogues, Put Up In Measured Doses Or For Retail Sale static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Hormones But Not Antibiotics; For Therapeutic Or Prophylactic Uses; Not Put Up In Measured Doses Or For Retail Sale (Excluding Insulin) static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Insulin But Not Antibiotics; For Therapeutic Or Prophylactic Uses; Not Put Up In Measured Doses Or For Retail Sale static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Insulin But Not Antibiotics; For Therapeutic Or Prophylactic Uses; Put Up In Measured Doses Or For Retail Sale static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Penicillins Or Derivatives Thereof, With A Penicillanic Acid Structure, Or Streptomycins Or Their Derivatives, For Therapeutic Or Prophylactic Uses, Other static version printer friendly pdf version
European Countries Market Value Of Medicaments Containing Vitamins; Provitamins; Derivatives And Intermixtures Thereof; For Therapeutic Or Prophylactic Uses; Put Up In Measured Doses Or For Retail Sale static version printer friendly pdf version
European Countries Market Value Of Medicaments Of Alkaloids Or Derivatives Thereof, Other static version printer friendly pdf version
European Countries Market Value Of Medicaments Of Other Antibiotics, Other static version printer friendly pdf version
European Countries Market Value Of Medicaments Of Penicillins, Streptomycins Or Deriv. Thereof, In Doses Or Other static version printer friendly pdf version
European Countries Market Value Of Opacifying Preparations For X-Ray Examinations; Diagnostic Reagents Designed To Be Administered To The Patient static version printer friendly pdf version
European Countries Market Value Of Other Medicaments For Therapeutic Or Prophylactic Uses static version printer friendly pdf version
European Countries Market Value Of Other Medicaments Of Mixed Or Unmixed Products static version printer friendly pdf version
European Countries Market Value Of Other Wadding, Gauze, Etc With Pharmaceutical Substances static version printer friendly pdf version
European Countries Market Value Of Sterile Surgical Catgut; Similar Suture Materials And Tissue Adhesives For Surgical Wound Closure; Laminaria And Laminaria Tents; Absorbable; Surgical Or Dental Haemostatics static version printer friendly pdf version
European Countries Market Value Of Vaccines For Human Medicine static version printer friendly pdf version
European Drug Markets for the Prevention and Treatment of Thrombosis static version printer friendly pdf version
European Endometriosis Therapeutics Market static version printer friendly pdf version
European Epilepsy Drugs Market static version printer friendly pdf version
European Hypolipidemic Pharmaceuticals Markets static version printer friendly pdf version
European Market Entry Strategies: Impact of Regulations, Pricing, Reimbursement, Parallel Trade and Generics Post-Accession (Executive Summary in Japanese) static version printer friendly pdf version
European Market for Picture Archive Communication Systems, 2004-2012 static version printer friendly pdf version
European Markets for Fibromyalgia Syndrome static version printer friendly pdf version
European Markets for Grid Computing in Life Sciences R&D static version printer friendly pdf version
European Markets for Medical Lasers static version printer friendly pdf version
European Markets for Pain Management Devices static version printer friendly pdf version
European Markets for Prescription Dermatology Products static version printer friendly pdf version
European markets for RFID in Pharmaceuticals static version printer friendly pdf version
European Neurodegenerative Disease Pharmaceuticals Markets static version printer friendly pdf version
European Nutraceuticals static version printer friendly pdf version
European Nutraceuticals static version printer friendly pdf version
European Ophthalmic Pharmaceuticals Markets static version printer friendly pdf version
European Patient Safety and Parallel Pharmaceutical Trade - A Potential Public Health Disaster? static version printer friendly pdf version
European Personalised Medicine and Pharmacogenomics Markets static version printer friendly pdf version
European Pharmaceutical eStrategies: Understanding Future Investment Trends static version printer friendly pdf version
European Pharmaceutical Intermediates Markets static version printer friendly pdf version
European Pharmaceutical Logistics Market Map 2004 static version printer friendly pdf version
European Pharmaceutical Logistics Market Map 2005 static version printer friendly pdf version
European Pharmaceutical Marketing: Launching Successful Brands static version printer friendly pdf version
European Pharmaceutical R&D Expenditure, 1980-2003 static version printer friendly pdf version
European Pharmaceuticals static version printer friendly pdf version
European Prescription Dermatology Markets static version printer friendly pdf version
European Psychotropic Pharmaceutical Markets static version printer friendly pdf version
European Testosterone Replacement Therapies Markets static version printer friendly pdf version
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence static version printer friendly pdf version
Evolving Approaches for Protein Drug Delivery static version printer friendly pdf version
Executing Change in the Pharma Industry - Prescription for Pfizer static version printer friendly pdf version
Executives AmerisourceBergen/PharMerica BusIntell Report static version printer friendly pdf version
Expanding a Brand: Statins and PPAR-Gamma Agonists to Treat Neurological Disease static version printer friendly pdf version
Expediting Drug and Biologics Development: A Strategic Approach 2006 static version printer friendly pdf version
Express Scripts Business Intelligence Report static version printer friendly pdf version
Extending Shelf Life--Additional Indications Drive Product Growth static version printer friendly pdf version
Eye Care in Argentina static version printer friendly pdf version
Eye Care in Austria static version printer friendly pdf version
Eye Care in Brazil static version printer friendly pdf version
Eye Care in Bulgaria static version printer friendly pdf version
Eye Care in Canada static version printer friendly pdf version
Eye Care in China static version printer friendly pdf version
Eye Care in Egypt static version printer friendly pdf version
Eye Care in Germany static version printer friendly pdf version
Eye Care In Hong Kong, China static version printer friendly pdf version
Eye Care in Hungary static version printer friendly pdf version
Eye Care in Israel static version printer friendly pdf version
Eye Care in Saudi Arabia static version printer friendly pdf version
Eye Care in Switzerland static version printer friendly pdf version
Eye Care in the UK static version printer friendly pdf version
Eye Care in the USA static version printer friendly pdf version
Eyewear in China 2005 static version printer friendly pdf version


^ Top



F

Facing Hipaa - What Pharmaceutical Companies Need to Know static version printer friendly pdf version
Falling Margins in Pharma - Increasing ROI through CRM (Market Focus) static version printer friendly pdf version
Financial Markets Research: Endo Pharmaceuticals’ Lidoderm - Physician Survey Indicates Increased Use Likely to Fuel Above-consensus Sales Growth static version printer friendly pdf version
Financial Markets Research: Indevus Pharmaceuticals Sanctura XR - Last-to-market Entrant Unlikely to Make an Impact in Crowded OAB Market static version printer friendly pdf version
Financial Markets Research: Renovis, Inc.s NXY-059 - Safety Profile and Unmet Need Could Drive Approval static version printer friendly pdf version
Financial Markets Research: Spectrum Pharmaceuticals Oral Satraplatin - Oral Therapy to Take Share in Second-line Hormone-refractory Prostate Cancer Market static version printer friendly pdf version
Five Factors that will Shape the Future of the Pharmaceutical Industry static version printer friendly pdf version
Follow-On Products as a Defense Against Generics static version printer friendly pdf version
Forecast Insight: Osteoarthritis static version printer friendly pdf version
Forecast of Pharmaceutical Market Opportunites to 2010 static version printer friendly pdf version
Foreign Pharmaceutical Companies 2001: Strategic Analysis - Japan static version printer friendly pdf version
Foreign Pharmaceutical Companies 2002: Strategic Analysis - Japan static version printer friendly pdf version
Foreign Pharmaceutical Companies 2003-2004: Strategic Analysis static version printer friendly pdf version
Forest Laboratories Inc Deals Briefing static version printer friendly pdf version
Forteo: A Case Study in Launching a Breakthrough Therapy in a Saturated Market static version printer friendly pdf version
Fourier Transform Infrared Spectrometry, 2nd Edition static version printer friendly pdf version
France Drug Industry static version printer friendly pdf version
France Pharmaceutical Industry static version printer friendly pdf version
France Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
France Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
France Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Fraud and Counterfeiting in the Pharmaceutical Industry static version printer friendly pdf version
From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus) static version printer friendly pdf version
From Structure to Function: In Vivo Molecular Imaging static version printer friendly pdf version
Fujisawa Pharmaceutical Co Ltd Deals Briefing static version printer friendly pdf version
Future Approaches in Coronary Artery Disease static version printer friendly pdf version
Future Cardiovascular and Diabetes Blockbusters- Where are they coming from? static version printer friendly pdf version
Future Drivers: Sales Forecast to 2005 static version printer friendly pdf version
Future of VLA-4 Antagonist Drugs and Implications for the Regulatory Process static version printer friendly pdf version


^ Top



G

G Protein-coupled Receptors: Molecular Pharmacology static version printer friendly pdf version
Gaining Competitive Advantage in Pharmaceutical Markets static version printer friendly pdf version
Gastric Relief Rx-to-otc Switch US Market Survey: Revised Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version
Gene Expression Reagent Market Revenue, 2005 static version printer friendly pdf version
Gene Expression Reagents Markets static version printer friendly pdf version
Gene Silencing With RNA Interference: A New Generation of Pharmaceuticals static version printer friendly pdf version
Gene Therapy: Current Status and Prospects static version printer friendly pdf version
Gene Therapy: It’s Finally Starting to Work! Immediate Opportunities and Future Implications  static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes - Gauchers Disease Drug Pipeline Report static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes - Turners Syndrome Drug Pipeline Report static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes Gauchers Disease  static version printer friendly pdf version
Genetic Diseases and Dysmorphic Syndromes Turners Syndrome  static version printer friendly pdf version
Genetic Effects on Environmental Vulnerability to Disease static version printer friendly pdf version
Genetic Technology News (Technical Insights) static version printer friendly pdf version
Genzyme Corporation Deals Briefing static version printer friendly pdf version
German Drug Industry static version printer friendly pdf version
German Pharmaceutical Industry static version printer friendly pdf version
Germany Pharmaceuticals & Healthcare Report Q1 2008 static version printer friendly pdf version
Germany Pharmaceuticals & Healthcare Report Q4 2006 static version printer friendly pdf version
Germany Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Getting Maximum Benefit from Combination Products static version printer friendly pdf version
Ghrelin: Pharmaceutical and Therapeutic Opportunities for the Treatment of Obesity static version printer friendly pdf version
Gilead Sciences Inc Deals Briefing static version printer friendly pdf version
Gilead: PharmaVitae Profile static version printer friendly pdf version
Glaucoma Medical Therapy: Principles and Management static version printer friendly pdf version
Glaxosmithkline Deals Briefing static version printer friendly pdf version
Glioblastoma - Is There life After Temodar? static version printer friendly pdf version
Glioblastoma Review - Temodar partnering pipeline drugs static version printer friendly pdf version
Global Bulk Drugs Industry Report static version printer friendly pdf version
Global Chiral Technology Markets static version printer friendly pdf version
Global CRO Spending Trends static version printer friendly pdf version
Global Drug Sales at Top Companies: 2002 vs. 2003 static version printer friendly pdf version
Global Drug Sales Market Share, 2002 vs. 2006 static version printer friendly pdf version
Global Drug Sales, 2002 vs. 2003 static version printer friendly pdf version
Global Generics static version printer friendly pdf version
Global Industry Monitor 35 Industries - Feb 07 static version printer friendly pdf version
Global Market for Catalyst Regeneration by Site Technology, 2002-2005 static version printer friendly pdf version
Global Market for Molecular Diagnostic Testing, 2000-2008 static version printer friendly pdf version
Global Market for Nucleic Acid Testing, 2000-2008 static version printer friendly pdf version
Global Market Share of Therapeutic Drugs by Category, 2002 vs. 2006 static version printer friendly pdf version
Global Markets for Breast Biopsy Procedures and Devices static version printer friendly pdf version
Global Markets for Lancets static version printer friendly pdf version
Global Oral Antibiotic Market, 2004-2010 static version printer friendly pdf version
Global Pharma Industry Monitor (January-March, 2008) static version printer friendly pdf version
Global Pharma Industry Monitor (October-December, 2007) static version printer friendly pdf version
Global Pharmaceutical Contract Manufacturing Markets static version printer friendly pdf version
Global Pharmaceutical Launches: Marketing Budgets and Staffing (Phase 3 to Post-Launch) static version printer friendly pdf version
Global Pharmaceutical Product Lifecycle Management Forecast 2006-2012 (Interactive Model) static version printer friendly pdf version
Global Pharmaceutical Sales, 2004-2012 static version printer friendly pdf version
Global Pharmaceutical Sales, Market Share and Growth Rate of Leading Products, 2003 static version printer friendly pdf version
Global Pharmaceutical Sales, Market Share and Growth Rate of Leading Therapy Classes, 2003 static version printer friendly pdf version
Global Pharmaceuticals static version printer friendly pdf version
Global Pharmaceuticals static version printer friendly pdf version
Global Pharmaceuticals & Biotechnology static version printer friendly pdf version
Global Pharmaceuticals - Yearly Update 2006 static version printer friendly pdf version
Global Pharmaceuticals and Biotechnology static version printer friendly pdf version
Global Pharmaceuticals and Medicine Manufacturing static version printer friendly pdf version
Global Pharmaceuticals Industry 2006 - Power Point Presentation (Editable) static version printer friendly pdf version
Global Pharmaceuticals, Biotechnology & Life Sciences static version printer friendly pdf version
Global Pipeline Review & Analysis of Hematological Malignancies static version printer friendly pdf version
Global Radiation Therapy Equipment Market: Opportunities on the Rise static version printer friendly pdf version
Global Revenues for Enzyme Inhibitors, 2005-2012 static version printer friendly pdf version
Global Sales of Abbott’s Kaletra, 2000-2006 static version printer friendly pdf version
Global Therapeutic Categories by Projects in Development, 2003 vs. 2004 static version printer friendly pdf version
Glucose Monitoring static version printer friendly pdf version
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development static version printer friendly pdf version
Good Clinical Practice: A Question and Answer Reference Guide 2006 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q2 2008 static version printer friendly pdf version
Greece Pharmaceuticals and Healthcare Report Q3 2007 static version printer friendly pdf version
Guide to Good Facility Design, 2nd Edition static version printer friendly pdf version
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China static version printer friendly pdf version
Guide to Venture Capital in European Biopharma  static version printer friendly pdf version


^ Top



H

H Lundbeck Deals Briefing static version printer friendly pdf version
Handbook of Pharmaceutica